
Centralized monitoring offers sponsors and CROs the program-wide oversight they need to successfully develop the medications of the future, says CluePoints CEO, Francois Torche.
Centralized monitoring offers sponsors and CROs the program-wide oversight they need to successfully develop the medications of the future, says CluePoints CEO, Francois Torche.
Central statistical monitoring can improve RBM solutions by efficiently detecting errors, sloppiness, tampering, and fraud.
Published: August 1st 2013 | Updated:
Published: December 4th 2019 | Updated: